These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27789411)

  • 21. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration.
    Esteras N; Rohrer JD; Hardy J; Wray S; Abramov AY
    Redox Biol; 2017 Aug; 12():410-422. PubMed ID: 28319892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
    Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
    Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
    Skrzypczyk A; Giri S; Bader A
    Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17).
    Haussmann R; Wysocki M; Brandt MD; Hermann A; Donix M
    Int Psychogeriatr; 2017 May; 29(5):869-871. PubMed ID: 27905268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episomal plasmid-based generation of an iPSC line from a 79-year-old individual carrying the APOE4/4 genotype: i11001.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):544-546. PubMed ID: 27789405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
    Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
    Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closing the tau loop: the missing tau mutation.
    McCarthy A; Lonergan R; Olszewska DA; O'Dowd S; Cummins G; Magennis B; Fallon EM; Pender N; Huey ED; Cosentino S; O'Rourke K; Kelly BD; O'Connell M; Delon I; Farrell M; Spillantini MG; Rowland LP; Fahn S; Craig P; Hutton M; Lynch T
    Brain; 2015 Oct; 138(Pt 10):3100-9. PubMed ID: 26297556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
    García-Cabrero AM; Guerrero-López R; Giráldez BG; Llorens-Martín M; Avila J; Serratosa JM; Sánchez MP
    Neurobiol Dis; 2013 Oct; 58():200-8. PubMed ID: 23774255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
    Zurita F; Galera T; González-Páramos C; Moreno-Izquierdo A; Schneiderat P; Fraga MF; Fernández AF; Garesse R; Gallardo ME
    Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.